Podcasts about leiden university medical centre

In this episode, we discuss how to facilitate discussions about reproductive choices. In this conversation, we are joined by Genetic Counsellor from The University of Cape Town, Tina Wessels, Director of ARC (Antenatal Results and Choices), Jane Fisher, and Emilia Bijsma from Leiden University Medical Centre.

Join us for the latest axSpA podcast brought to you by the CSF! This month Dr Sofia Ramiro, consultant rheumatologist and senior researcher at Leiden University Medical Centre and Zuyderland Medical Centre, is joined once again by experts with a wealth of clinical knowledge. Joining her is Hideto Kameda, Professor of Internal Medicine at Toho University as well as Atul Deodhar, Professor of Medicine and Medical Director of Rheumatology Clinics in the Division of Arthritis & Rheumatic Diseases at Oregon Health & Science University in Portland, USA. Also joining this insightful group is Xenofon Baraliakos, Professor of Internal Medicine and Rheumatology at the Ruhr-University in Bochum, and Medical Director of the rheumatology centre Rheumazentrum Ruhrgebiet in Herne, Germany In the first paper discussed, the authors compared the efficacy and safety of bimekizumab with biologic/targeted synthetic disease-modifying antirheumatic drugs in nr-axSpA and AS. Our second paper then goes on to identify distinct clinical clusters based on patient demographics and baseline clinical indicators from the clinical development programme of secukinumab in patients with a variety of rheumatological conditions.

Professor Hideto Kameda, Professor of Internal Medicine at Toho University in Japan, is joined by Professor Xenofon Baraliakos, Professor of Internal Medicine and Rheumatology at the Ruhr-University in Bochum, and a senior consultant and scientific coordinator of the rheumatology centre Rheumazentrum Ruhrgebiet in Herne, Germany, Dr Sofia Ramiro, consultant rheumatologist and senior researcher at Zuyderland Medical Centre and Leiden University Medical Centre in the Netherlands as well as, Atul Deodhar Professor of Medicine and Medical Director of Rheumatology Clinics in the Division of Arthritis & Rheumatic Diseases at Oregon Health & Science University in Portland, USA, to discuss the safety and efficacy of Upadacitinib. The first paper evaluated the 52-week safety, tolerability, and efficacy of updacitinib in the SELECT-AXIS 2 study in patients with AS and an inadequate response to bDMARDs and the second paper then goes on to describe, via a narrative review, the safety and efficacy of updacitinib in axSpA

Dr Sofia Ramiro, consultant rheumatologist and senior researcher at Zuyderland Medical Centre and Leiden University Medical Centre in the Netherlands, is joined by Professor Hideto Kameda, Professor of Internal Medicine at Toho University and Atul Deodhar, Professor of Medicine and Medical Director of Rheumatology Clinics in the Division of Arthritis & Rheumatic Diseases at Oregon Health & Science University in Portland, USA to discuss the Efficacy and Safety of Ixekizumab & Tildrakizumab. In the first paper discussed, it describes the safety and efficacy of ixekizumab treatment in patients with r-axSpA and nr-axSpA for up to 156 weeks. The second study discussed goes on to assess the safety and efficacy of tildrakizumab in patients with active AS.

Professor Peter Nash from the Griffith University in Brisbane, is joined by Doctor Sofia Ramiro, a Consultant Rheumatologist and Senior Researcher at Leiden University Medical Centre to discuss her recent paper 'Do Fatty Lesions Explain the Effect of Inflammation on New Syndesmophytes in Patients with Radiographic Axial Spondyloarthritis? Results From the SIAS Cohort and ASSERT Trial'

Welcome to RNN Café to informally discuss topics of interest for radiology. In this episode focus is on workflow interruptions and a possible solution: RadConnect. Special guests are Kenneth Hergaarden, PhD-Student at the Cardio Vascular Imaging Group (CVIG), Department of Radiology, Leiden University Medical Centre, The Netherlands and Merlijn Sevenster, Royal Philips, The Netherlands. We discuss the effects of workflow interruptions on our work as radiologists, based on a recent publication by Shah et al. from the Nationwide Children's Hospital, Columbus, OH, USA entitled 'Workflow Interruptions and Effect on Study Interpretation Efficiency' (https://doi.org/10.1067/j.cpradiol.2022.06.003). Next a potential solution to the problem is discussed: 'RadConnect' a tool in development for asynchronous communication between radiology technicians and radiologists, later to be extended to other medical professionals as 'MedConnect'. Check the ranking of RNN in the Top worldwide best Radiology Podcasts: https://blog.feedspot.com/radiology_podcasts/ --- Send in a voice message: https://anchor.fm/radiologica/message

This is the first RNN podcast as RNN Café to informally discuss topics of interest for radiology. In this episode focus is on Artificial Intelligence (AI). Special guest is Omar Hertgers, PhD-Student at the Cardio Vascular Imaging Group (CVIG), Department of Radiology, Leiden University Medical Centre, The Netherlands. Omar informs us about 3 topics of his research program relating to AI application in radiological healthcare. 1. Local adaption of externally developed AI-applications; 2. rAIdiology AI lab; 3. Worklist prioritization. RNN ranks #29 in the Top worldwide best Radiology Podcasts: https://blog.feedspot.com/radiology_podcasts/ --- Send in a voice message: https://anchor.fm/radiologica/message

A team from the Leiden University Medical Centre and Philips Healthtech won a Facebook challenge on AI-based reconstruction of sparcely sampled k-space to speed up MRI acquisitions. In this episode an interview with winning team members.

Eva Viho, PhD student at Leiden University Medical Centre, talks to NEN about her recent publication "Corticosteroid action in the brain: the potential of selective receptor modulation." Interview by Dr Julie Ann Lough Viho, E.M.G., Buurstede J.C., Mahfouz A., Koorneef L.L., van Weert L.T.C.M., Houtman R., Hunt H.J., Kroon J., Meijer O.C. (2019) Corticosteroid action in the brain: the potential of selective receptor modulation. Neuroendocrinology.DOI:10.1159/000499659    

Dr Beerend Hierk is an Assistant Professor and Dr Katerina Bogomolova is a PhD student at Leiden University Medical Centre in Holland. In this episode I talk to Beerend and Katerina about anatomy teaching at LUMC and the development and evaluation of an innovative mixed reality app. You can download the free Mixed Reality app – Dynamic Anatomy – here and learn more about the project here.   To continue the conversation use: #AnatPodcast Follow: @AnatEducPodcast Visit: anatomypodcast.co.uk for more information   This episode is sponsored by: The American Association of Anatomists. For information about upcoming events, membership details and much more, visit www.anatomy.org and @anatomymeeting. The International Association of Medical Science Education (IAMSE). For more information on meetings, membership options and funding, visit www.iamse.org and @iamse. Adam Rouilly. For information on their wide range of products to support all aspects of healthcare education, visit www.adam-rouilly.co.uk and @AdamRouilly.    

Type 2 diabetes is a complex systems disease, caused by interactions between lifestyle and genes. It is an illusion to believe that it can be cured by medication. Lifestyle change should always be at the heart of treatment. Hanno Pijl is an internist-endocrinologist and professor of Diabetology at the Leiden University Medical Center (LUMC) In Leiden, The Netherlands. He co-authored over 250 papers in peer reviewed scientific journals, primarily related to obesity and type 2 diabetes. He has been a member of the Dutch Health Council (standing committee on nutrition) from 2008-2016. He currently co-chairs the Dutch Innovation center for Lifestyle Medicine (www.nilg.eu), a joint effort of LUMC and the Dutch Organisation of Applied Science (TNO) focusing on lifestyle interventions in health care.   Esther van Zuuren is a dermatologist at the Leiden University Medical Centre, but apart from that and more relevant for now is that her expertise lies in Evidence Based Medicine. She has been with Cochrane for almost 20 years, has held the position of Key Editor and Methods editor for Cochrane Skin group for several years and conducted over 30 systematic reviews on a wide variety of topics. Furthermore, she is member of the GRADE working group, is a Recommendations Editor for DynaMed Plus (clinical evidence-based reference tool for clinicians) and Associate Editor for Systematic Reviews for the British Journal of Dermatology. In our 20 min conversation we discuss Dietary advice for people with type 2 diabetes The importance of other lifestyle measures Effects of lifestyle intervention in clinical practice Patient preferences

Contrary to the long held contention that low fat diets are best for people with type 2 diabetes (DM2), the totality of current evidence suggests that low carb diets are at least as effective in ameliorating metabolic health in DM2. In fact, low carb seems to be somewhat better, particularly in the short to medium term, although the evidence is of moderate certainty.   On this week’s episode Prof Hanno Pijl (@HannoPijl) and dr Esther van Zuuren (@Ezzoef) join Dr Aseem Malhotra (@DrAseemMalhotra) to discuss the most appropriate diet for people with DM2   Hanno Pijl is an internist-endocrinologist and professor of Diabetology at the Leiden University Medical Center (LUMC) In Leiden, The Netherlands. He co-authored over 250 papers in peer reviewed scientific journals, primarily related to obesity and type 2 diabetes. He has been a member of the Dutch Health Council (standing committee on nutrition) from 2008-2016. He currently co-chairs the Dutch Innovation center for Lifestyle Medicine (www.nilg.eu), a joint effort of LUMC and the Dutch Organisation of Applied Science (TNO) focusing on lifestyle interventions in health care.   Esther van Zuuren is a dermatologist at the Leiden University Medical Centre, but apart from that and more relevant for now is that her expertise lies in Evidence Based Medicine. She has been with Cochrane for almost 20 years, has held the position of Key Editor and Methods editor for Cochrane Skin group for several years and conducted over 30 systematic reviews on a wide variety of topics. Furthermore, she is member of the GRADE working group, is a Recommendations Editor for DynaMed Plus (clinical evidence-based reference tool for clinicians) and Associate Editor for Systematic Reviews for the British Journal of Dermatology   In our 20 min conversation we discuss   Efficacy of low fat versus low carb diets in the treatment of type 2 diabetes The method of weighing the certainty of evidence we used in our systematic review of the literature Dietary recommendations for people with type 2 diabetes https://academic.oup.com/ajcn/article-abstract/108/2/300/5051863

Immunotherapy has been approved for several indications in Oncology, resulting in an increasing number of physicians that use it to treat their patients. In this podcast, Teresa Amaral, member of the ESMO YOC, interviews Professor John Haanen (Head of the Division of Medical Oncology and Staff Scientist in the Division of Immunology; Professor of Translational Immunotherapy of Cancer at Leiden University Medical Centre, the Netherlands) on the topic: “Questions asked in everyday practice: Immune Checkpoint Inhibitors”. Currently, there is no consensus about how long should we treat patients with immunotherapy and the optimal duration might also be different considering the tumor type (e.g. melanoma, NSCLC). In some patients, stopping early due to adverse events doesn’t seem to be detrimental, but the follow-up time is still short to make definitive assumptions. When treating a patient with a previous autoimmune disease, several aspects need to be considered, namely, which type of immunosuppression is the patient receiving now, in which dosage and how long has the autoimmune disease been stable. Patients that received a solid organ transplant pose an extra challenge. For patients that develop grade 4 autoimmune adverse events, re-treatment with immunotherapy should be extensively discussed. In case of severe autoimmune toxicity that does not respond to the treatments referred in the guidelines, and if the treating physician is not experienced with escalating immunosuppressive therapy, consultation with other centers with more familiarity and expertise on this topic should be considered. Read the abstract on the ESMO Open website: http://dx.doi.org/10.1136/esmoopen-2018-000395.

Welcome back to the new VTE Dublin Podcast where you’ll find all the recent talks from the VTE Dublin Conference. Professor Menno Huisman is Professor of Thrombosis and Hemostasis in Leiden University Medical Centre. His research is focused on the clinical aspects of venous and arterial thromboembolic disorders, with special interest on the diagnosis and treatment of […]

This podcast features a story about the desire to have kids and the fear of losing them. Australian blogger Stephanie Ernst was struck by an incredibly rare disease which affects identical twins. The podcast highlights her struggle with the disease Twin to Twin Transfusion Syndrome – TTTS – and its closely associated variant TAPS – Twin Anemia Polycythemia Sequence. It features Dr. Enrico Lopriore head of the department of Neonatology at the Leiden University Medical Centre. TAPS was discovered by the team at the Leiden hospital. For more information on TTTS and TAPS visit the TTTS Foundation Or the TTTS Grief support group TTTS Grief support group Stephanie’s blog is The Inbuggering Diaries Contact Here in Holland email: hereinholland@gmail.com Facebook page WhatsApp +31 (0) 6 12 42 83 87 Twitter: @HereHolland. Support the show (https://www.patreon.com/hereinholland)

Professor Albert Dahan, head of the Anesthesia and Pain Research Unit at Leiden University Medical Centre, talks about why this common and dangerous phenomenon is under-reported in the literature and as a result, why he has taken this unusual investigative approach. Professor Dahan highlights the paper's main findings including the emerging importance of CYP2D6 genetic polymorphisms and future directions for research.

Zhe Zhao joined Oxford in 2010, after completing an undergraduate degree in Biological Science at Tsinghua University in Beijing and a Msc at Leiden University Medical Centre. He works on Transcription Regulation in Coronary Development. Every year, about 65 DPhil students start a life changing experience in the Nuffield Department of Medicine in Oxford. The Department offers a highly competitive studentship for our DPhil programme to outstanding candidates of any nationality. The candidates are judged on the basis of their academic and research potential. The NDM Prize Studentship is a four year course which includes full payment of all fees and an annual stipend.